Amneal Pharmaceuticals, Inc. Liquidation Value
AMRX
Other
Cash & Equivalents
$282.03M
As of 2025-12-31
Current Price: N/A
Key Metrics
Cash Liquidation Value
Cash minus Total Obligations
Cash: $282.03M
Total Obligations: -$3.56B
$-3.28B
Per share: $-3,281,889.00
Period: 2025-12-31
Liquid Liquidation Value
Cash + AR minus Total Obligations
Cash: $282.03M
AR: $9.73M
Total Obligations: -$3.56B
$-3.27B
Per share: $-3,272,157.00
Period: 2025-12-31
Operating Liquidation Value
Cash + AR + Inventory minus Total Obligations
Cash: $282.03M
AR: $9.73M
Inventory: $606.30M
Total Obligations: -$3.56B
$-2.67B
Per share: $-2,665,855.00
Period: 2025-12-31
Build your own liquidation scenario
Adjust asset discounts and liability assumptions to see how assumptions affect the numbers.
Liquidation Ladder
| Metric | Total | Per Share |
|---|---|---|
| Cash Liquidation Value | $-3.28B | $-3,281,889.00 |
| Liquid Liquidation Value | $-3.27B | $-3,272,157.00 |
| Operating Liquidation Value | $-2.67B | $-2,665,855.00 |
Key Components (as of 2025-12-31)
| Cash & Equivalents | $282.03M |
| Accounts Receivable | $9.73M |
| Inventory | $606.30M |
| Current Liabilities | $881.63M |
| Long-term Debt | $2.57B |
| Op. Lease Liability | $58.80M |
| Finance Lease | $58.37M |
| Shares Outstanding | N/A |
Explore all 222 XBRL tags and build your own scenario → Open Calculator
Historical
| Period | Cash | AR | Inventory | AP | Curr Liab | LT Debt | Op Lease | Fin Lease |
|---|---|---|---|---|---|---|---|---|
| 2025-12-31 | $282.03M | $9.73M | $606.30M | N/A | $881.63M | $2.57B | $58.80M | $58.37M |
| 2025-09-30 | $201.25M | $17.07M | $614.50M | $266.36M | $862.11M | $2.57B | N/A | N/A |
| 2025-06-30 | $71.54M | $20.07M | $608.97M | $205.81M | $1.11B | $2.15B | N/A | N/A |
| 2025-03-31 | $59.19M | $22.95M | $601.43M | $192.53M | $1.08B | $2.15B | N/A | N/A |
▼ Community Notes